These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10731049)

  • 81. Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.
    Song W; Tang Z; Li M; Lv S; Sun H; Deng M; Liu H; Chen X
    Acta Biomater; 2014 Mar; 10(3):1392-402. PubMed ID: 24316362
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Influence of Cremophor EL and genetic polymorphisms on the pharmacokinetics of paclitaxel and its metabolites using a mechanism-based model.
    Fransson MN; Gréen H; Litton JE; Friberg LE
    Drug Metab Dispos; 2011 Feb; 39(2):247-55. PubMed ID: 21056987
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Taxane-mediated antiangiogenesis in vitro: influence of formulation vehicles and binding proteins.
    Ng SS; Figg WD; Sparreboom A
    Cancer Res; 2004 Feb; 64(3):821-4. PubMed ID: 14871806
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cimetidine enhances cisplatin toxicity in mice.
    Dorr RT; Soble MJ
    J Cancer Res Clin Oncol; 1988; 114(1):1-2. PubMed ID: 3350834
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Induction of oxidative stress by Taxol® vehicle Cremophor-EL triggers production of interleukin-8 by peripheral blood mononuclear cells through the mechanism not requiring de novo synthesis of mRNA.
    Ilinskaya AN; Clogston JD; McNeil SE; Dobrovolskaia MA
    Nanomedicine; 2015 Nov; 11(8):1925-38. PubMed ID: 26282378
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cisplatin incorporated in microspheres: development and fundamental studies for its clinical application.
    Fujiyama J; Nakase Y; Osaki K; Sakakura C; Yamagishi H; Hagiwara A
    J Control Release; 2003 May; 89(3):397-408. PubMed ID: 12737842
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cisplatin-Loaded Thermosensitive Liposomes Functionalized with Hyaluronic Acid: Cytotoxicity and In Vivo Acute Toxicity Evaluation.
    Gomes IP; Silva JO; Cassali GD; De Barros ALB; Leite EA
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839905
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dimethylsulfoxide excerbates cisplatin-induced cytotoxicity in Ehrlich ascites carcinoma cells.
    Osman AM; Alqahtani AA; Damanhouri ZA; Al-Harthy SE; ElShal MF; Ramadan WS; Kamel F; Osman MA; Khan LM
    Cancer Cell Int; 2015; 15():104. PubMed ID: 26516314
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice.
    Khynriam D; Prasad SB
    Cell Biol Toxicol; 2001; 17(6):357-70. PubMed ID: 11787858
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cisplatin microcrystals suspended in oil--toxicity in mice.
    Tsujimoto H; Hagiwara A; Sakakura C; Sasaki S; Osaki K; Ohyama T; Sakakibara T; Takahashi T
    Anticancer Drugs; 1993 Jun; 4(3):377-80. PubMed ID: 8395260
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A comparative study of acute toxicity of drugs used during anticancer therapy in healthy and tumor-bearing mice.
    Scorza Barcellona P; Campana A; Rossi V; Corradino C; Silvestrini B
    Arch Toxicol Suppl; 1984; 7():90-3. PubMed ID: 6596028
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Vehicles for lipophilic drugs: implications for experimental design, neuroprotection, and drug discovery.
    Rivers-Auty J; Ashton JC
    Curr Neurovasc Res; 2013 Nov; 10(4):356-60. PubMed ID: 23937198
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Toxicity and cytostatic effect of PtCl2(NH3)2 after i. v. and i. t. injection (author's transl)].
    Wenzel M; Schneider M; Bier J
    Z Naturforsch C Biosci; 1980; 35(9-10):848-50. PubMed ID: 7192458
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review.
    Li Y; Li Y; Li J; Pi G; Tan W
    Onco Targets Ther; 2014; 7():1361-6. PubMed ID: 25114574
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of antimitotic agents bound to a macromolecular carrier in normal or cancer cells. Importance of the mode of binding of the agent to the carrier.
    Heinen E; Bassleer R; Desaive C
    Eur J Cancer (1965); 1978 Sep; 14(9):1005-11. PubMed ID: 710485
    [No Abstract]   [Full Text] [Related]  

  • 96. Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer.
    Gelderblom H; Sparreboom A; de Jonge MJ; Loos WJ; Wilms E; Mantel MA; Hennis B; Camlett I; Verweij J; van der Burg ME
    Br J Cancer; 2001 Oct; 85(8):1124-9. PubMed ID: 11710824
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Differential alteration of cisplatin cytotoxicity and myelotoxicity by the paclitaxel vehicle cremophor EL.
    Badary OA; Abdel-Naim AB; Khalifa AE; Hamada FM
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):339-44. PubMed ID: 10731049
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice.
    Badary OA; Al-Shabanah OA; Al-Gharably NM; Elmazar MM
    Anticancer Drugs; 1998 Oct; 9(9):809-15. PubMed ID: 9840728
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL.
    de Vos AI; Nooter K; Verweij J; Loos WJ; Brouwer E; de Bruijn P; Ruijgrok EJ; van der Burg ME; Stoter G; Sparreboom A
    Ann Oncol; 1997 Nov; 8(11):1145-50. PubMed ID: 9426335
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studies.
    Gelderblom H; Loos WJ; Verweij J; van der Burg ME; de Jonge MJ; Brouwer E; Nooter K; Stoter G; Sparreboom A
    Eur J Cancer; 2002 Jan; 38(1):205-13. PubMed ID: 11750851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.